Jagsonpal Pharma to consider first-ever share buyback; Board meeting on March 12, 2026

• Jagsonpal Pharmaceutical Ltd., a ₹1,100 crore drugmaker, will consider its first-ever share buyback proposal.
• The company's board of directors is set to meet on Thursday, March 12, 2026, to approve the buyback of fully-paid up equity shares.
• This marks the first instance the company will approve a share buyback, according to Bombay Stock Exchange (BSE) data.
• Jagsonpal Pharma previously issued bonus shares in 2004 and carried out a stock split in 2025.
• Shares ended 2.5% lower at ₹169.05, with significant declines over the past month and six months.